MedTrace Logo

Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue

NCT00184210 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-03-22

No results posted yet for this study

Summary

Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed by other methods, such as histopathology.

The MR spectral profiles are compared to clinical findings such as the patients diagnosis, lymph node status and tumor size.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER

  • The Norwegian Women´s Public Health Association

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Tone F Bathen, PhD · Norwegian University of Technology and Science

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184210 on ClinicalTrials.gov